Gamsjäger Thomas, Brenner Lydia, Schaden Eva, Sitzwohl Christian, Weinstabl Christian
Department of Anesthesia, General Intensive Care and Pain Control Medical, University of Vienna, Vienna, Austria.
Pediatr Crit Care Med. 2009 Mar;10(2):163-5. doi: 10.1097/PCC.0b013e3181956b76.
In pediatric intensive care, two approaches to parenteral nutrition are available: individualized admixtures or commercial standard solutions. Even though individualized admixtures can be tailored to sometimes highly intricate requirements, standard solutions are able to meet the demands of the majority of pediatric patients. To address the growing importance of costs in intensive care, we investigated whether relevant differences between individualized admixtures and standard solutions in terms of costs can be found.
Retrospective analysis.
University-affiliated intensive care unit.
Fifty consecutively admitted pediatric patients requiring parenteral nutrition.
None.
Comparison of actual costs of individualized admixtures and theoretical costs of standard solutions. Mean actual costs of individualized admixtures of Euro 81.78 (+/- 16.33) per patient and day were significantly higher than the theoretical costs of standard solutions of Euro 61.21 (+/- 6.55). Cost differences increased with patients' body weights.
Parenteral nutrition with standard solutions offers the potential of a relevant cost reduction compared with individualized admixtures in critically ill children.
在儿科重症监护中,肠外营养有两种方法可供选择:个体化混合制剂或商业标准溶液。尽管个体化混合制剂有时可以根据非常复杂的需求进行定制,但标准溶液能够满足大多数儿科患者的需求。为了应对重症监护中成本日益增加的重要性,我们调查了在成本方面个体化混合制剂和标准溶液之间是否存在相关差异。
回顾性分析。
大学附属医院重症监护病房。
连续收治的50例需要肠外营养的儿科患者。
无。
比较个体化混合制剂的实际成本和标准溶液的理论成本。每名患者每天个体化混合制剂的平均实际成本为81.78欧元(±16.33),显著高于标准溶液的理论成本61.21欧元(±6.55)。成本差异随患者体重增加而增大。
与个体化混合制剂相比,标准溶液肠外营养在危重症儿童中具有显著降低成本的潜力。